OPDUALAG NIVOLUMAB/RELATLIMAB)
DEAD

Serial Number

88805781

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

Feb 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OPDUALAG NIVOLUMAB/RELATLIMAB) Trademark

Serial Number: 88805781

OPDUALAG NIVOLUMAB/RELATLIMAB) is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on February 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

February 21, 2020

Registration Date

Not Registered

Published for Opposition

August 3, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of cancer, all of the foregoing comprising monoclonal antibodies

Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; Providing a website featuring educational information in the field of healthcare and pharmaceutical preparations; all of the foregoing involving monoclonal antibodies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 30, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 30, 2023 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 2, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 2, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2023 EXRA
SOU EXTENSION 3 GRANTED
Mar 7, 2023 EX3G
SOU EXTENSION 3 FILED
Mar 7, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 7, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2022 EXRA
SOU EXTENSION 2 GRANTED
Sep 13, 2022 EX2G
SOU EXTENSION 2 FILED
Sep 13, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 13, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2022 EXRA
SOU EXTENSION 1 GRANTED
Mar 7, 2022 EX1G
SOU EXTENSION 1 FILED
Mar 7, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 7, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 3, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2021 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 30, 2021 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2021 CRFA
ASSIGNED TO LIE
Jun 22, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Apr 9, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2021 TROA
PETITION TO REVIVE-GRANTED
Apr 8, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 8, 2021 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 26, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2020 NWOS
NEW APPLICATION ENTERED
Feb 25, 2020 NWAP